Dogwood Therapeutics, Inc.
DWTX
$5.37
$1.1025.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -12.35M | -5.73M | -4.68M | -5.07M | -5.30M |
| Total Depreciation and Amortization | 12.20K | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 58.40K | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.07M | 530.50K | 584.50K | 597.30K | 620.00K |
| Change in Net Operating Assets | -581.30K | 1.07M | -83.90K | 363.80K | -194.50K |
| Cash from Operations | -8.79M | -4.13M | -4.18M | -4.11M | -4.87M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 3.76M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 3.76M | -- | -- | -- | -- |
| Total Debt Issued | 15.32M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.45M | 1.45M | 2.61M | 1.16M | 1.16M |
| Repurchase of Common Stock | -70.60K | -70.20K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 16.70M | 1.38M | 2.61M | 1.16M | 1.16M |
| Foreign Exchange rate Adjustments | -144.60K | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 11.53M | -2.75M | -1.57M | -2.95M | -3.71M |